Figure 1.
Effect of imetelstat on hemoglobin (Hgb), platelet and leukocyte counts in three patients with refractory anemia with ring sideroblasts with (ex178520) or without (ex176837 and ex178418) thrombocytosis. ex176837: T1 duration=28 weeks and treatment ongoing; ex178418: T1 duration=37 weeks and treatment ongoing; ex178520: T1 duration=9 weeks and off-study July 2014. ANC, absolute neutrophil; WBC, white blood cell.